The Benefits of Docetaxel Plus Cisplatin and 5-Fluorouracil Induction Therapy in Conversion to Curative Treatment for Locally Advanced Esophageal Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

The Benefits of Docetaxel Plus Cisplatin and 5-Fluorouracil Induction Therapy in Conversion to Curative Treatment for Locally Advanced Esophageal Squamous Cell Carcinoma

Published:2019-04-09 Issue:8 Volume:43 Page:2006-2015
ISSN:0364-2313
Container-title:World Journal of Surgery
language:en
Short-container-title:World J Surg

Author:

Takeuchi Masashi,Kawakubo Hirofumi,Mayanagi Shuhei,Yoshida Kayo,Irino Tomoyuki,Fukuda Kazumasa,Nakamura Rieko,Wada Norihito,Takeuchi Hiroya,Kitagawa Yuko

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00268-019-05000-3.pdf

Reference33 articles.

1. Rustgi AK, El-Serag HB (2014) Esophageal carcinoma. N Engl J Med 371:2499–2509

2. Gamliel Z, Krasna MJ (2005) Multimodality treatment of esophageal cancer. Surg Clin North Am 85:621–630

3. Ohtsu A, Boku N, Muro K et al (1999) Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17:2915–2921

4. Matsubara T, Ueda M, Kokudo N et al (2001) Role of esophagectomy in treatment of esophageal carcinoma with clinical evidence of adjacent organ invasion. World J Surg 25:279–284. https://doi.org/10.1007/s002680020060

5. Markar SR, Karthikesalingam A, Penna M et al (2013) Assessment of short-term clinical outcomes following salvage esophagectomy for the treatment of esophageal malignancy: systematic review and pooled analysis. Ann Surg Oncol 21:922–931

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Esophagectomy in patients with esophageal squamous cell carcinoma and distant nodal metastasis;Diseases of the Esophagus;2024-08-16

2. Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort study;Strahlentherapie und Onkologie;2024-08-12

3. Conversion Chemoradiotherapy Combined with nab-paclitaxel plus Cisplatin in Patients with Locally Advanced Borderline-Resectable or Unresectable Esophageal Squamous Cell Carcinoma: a Phase Ⅰ/Ⅱ Prospective Cohort Study;2024-02-26

4. Oligometastases of Esophageal Squamous Cell Carcinoma: A Review;Cancers;2024-02-07

5. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1;Esophagus;2023-03-18